Organigram has distribution in all 10 Canadian provinces and has now received licensing approval from Health Canada for its Phase 4A expansion efforts, which are expected to bring its annual production capacity to 61,000 kg The company is well-positioned for Canada’s anticipated edibles and derivative legalization, expected in October 2019, with expanding production capacity, R&D […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.